title: Correlation of specific platelet activation markers with carotid arterial wall thickness.
abstract: Many studies have shown increased platelet activation in patients with coronary artery, cerebrovascular and peripheral vascular diseases. However, the temporal relationship between platelet activation and arterial atherosclerosis is unclear. To answer this basic question, we measured the plasma concentrations of two specific platelet activation markers, beta-thromboglobulin (beta TG) and platelet factor 4 (PF4) in 459 cases with increased carotid arterial wall thickness and 459 age-, sex-and race-matched controls selected from a cohort of 15,800 men and women, aged 45-64 who participated in the Atherosclerosis Risk in Communities Study. These participants had no acute vascular symptoms or known cardiovascular disease. The mean values of beta TG and PF4 were significantly higher in cases than in controls. However, when analyzed by quartiles using conditional logistic regression, only beta TG exhibited a significant association with carotid wall thickness, while PF4 did not. The odds ratio (OR) determined by multivariate logistic regression analysis was significantly higher for the uppermost quartile of beta TG (OR=1.7, 95% CI 1.1-2.5) compared to the lower 3 quartiles. This OR was 2.3 in white men (95% CI 1.2-4.2), 1.4 in white women (95% CI 0.6-3.0) and 1.0 in blacks (95% CI 0.4-2.5). This study indicates that plasma beta TG may be useful as a marker for early atherosclerosis in middle aged adults, particularly in white men. It also suggests that platelet activation has an independent role in the pathogenesis of atherosclerosis, although the possibility that this may be a response to carotid atherosclerosis cannot be excluded.
authors.affiliation: Division of Hematology, University of Texas, Houston 77030, USA.
authors.forename: H B
authors.initials: HB
authors.lastname: Ghaddar
authors.forename: J
authors.initials: J
authors.lastname: Cortes
authors.forename: V
authors.initials: V
authors.lastname: Salomaa
authors.forename: J D
authors.initials: JD
authors.lastname: Kark
authors.forename: C E
authors.initials: CE
authors.lastname: Davis
authors.forename: A R
authors.initials: AR
authors.lastname: Folsom
authors.forename: G
authors.initials: G
authors.lastname: Heiss
authors.forename: V
authors.initials: V
authors.lastname: Stinson
authors.forename: K K
authors.initials: KK
authors.lastname: Wu
mesh_terms: D015415:Biomarkers / Q000737:chemistry; D002340:Carotid Artery Diseases / Q000097:blood* / Q000473:pathology; D016022:Case-Control Studies; D004730:Endothelium, Vascular / Q000473:pathology*; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000097:blood* / Q000473:pathology; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015539:Platelet Activation / Q000502:physiology*; D010978:Platelet Factor 4 / Q000032:analysis*; D001620:beta-Thromboglobulin / Q000032:analysis*
chemical_list: D015415:Biomarkers; D001620:beta-Thromboglobulin; D010978:Platelet Factor 4